Quantbot Technologies LP Makes New $957,000 Investment in MaxLinear, Inc $MXL

Key Points

• Quantbot Technologies LP has taken a new position in MaxLinear, Inc, acquiring 88,083 shares valued at approximately $957,000.
• Multiple institutional investors have increased their stakes in MaxLinear, with UBS AM raising its position by 5.5% and GAMMA Investing LLC increasing by an impressive 889.1%.
• MaxLinear's stock price target has been boosted by several analysts, with Benchmark setting a new target at $25.00, and the consensus rating for the stock is currently a "Hold" with an average target of $19.31.

Quantbot Technologies LP bought a new position in shares of MaxLinear, Inc (NASDAQ:MXL - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 88,083 shares of the semiconductor company's stock, valued at approximately $957,000. Quantbot Technologies LP owned 0.10% of MaxLinear as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MXL. Raymond James Financial Inc. bought a new position in MaxLinear during the fourth quarter worth about $1,671,000. Guggenheim Capital LLC bought a new position in shares of MaxLinear in the fourth quarter valued at approximately $469,000. First Trust Advisors LP bought a new position in shares of MaxLinear in the fourth quarter valued at approximately $280,000. MetLife Investment Management LLC boosted its position in shares of MaxLinear by 7.3% in the fourth quarter. MetLife Investment Management LLC now owns 48,592 shares of the semiconductor company's stock valued at $961,000 after acquiring an additional 3,314 shares during the period. Finally, Stifel Financial Corp boosted its position in shares of MaxLinear by 97.3% in the fourth quarter. Stifel Financial Corp now owns 47,253 shares of the semiconductor company's stock valued at $935,000 after acquiring an additional 23,300 shares during the period. Institutional investors own 90.79% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently commented on MXL. Benchmark raised their price objective on shares of MaxLinear from $20.00 to $25.00 and gave the company a "buy" rating in a research report on Thursday, July 24th. Stifel Nicolaus raised their price objective on shares of MaxLinear from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, July 18th. Loop Capital restated a "hold" rating and issued a $15.00 price objective (up from $10.00) on shares of MaxLinear in a research report on Monday, August 4th. Wells Fargo & Company raised their price objective on shares of MaxLinear from $13.00 to $18.00 and gave the company an "equal weight" rating in a research report on Thursday, July 24th. Finally, Susquehanna raised their price objective on shares of MaxLinear from $11.00 to $15.00 and gave the company a "neutral" rating in a research report on Tuesday, July 22nd. Four investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $19.31.

Insider Activity at MaxLinear

In other MaxLinear news, insider Steven G. Litchfield sold 102,157 shares of MaxLinear stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $17.28, for a total transaction of $1,765,272.96. Following the transaction, the insider directly owned 312,203 shares of the company's stock, valued at approximately $5,394,867.84. This trade represents a 24.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 7.80% of the company's stock.

MaxLinear Price Performance

MaxLinear stock traded down $0.48 during mid-day trading on Wednesday, hitting $16.74. 1,424,105 shares of the company traded hands, compared to its average volume of 1,615,227. MaxLinear, Inc has a one year low of $8.35 and a one year high of $25.73. The stock has a market cap of $1.46 billion, a price-to-earnings ratio of -6.78 and a beta of 1.69. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.14 and a current ratio of 1.55. The stock has a fifty day moving average price of $15.13 and a 200-day moving average price of $13.25.

MaxLinear (NASDAQ:MXL - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The semiconductor company reported $0.02 EPS for the quarter, hitting the consensus estimate of $0.02. The firm had revenue of $108.81 million for the quarter, compared to the consensus estimate of $104.94 million. MaxLinear had a negative net margin of 55.53% and a negative return on equity of 18.16%. The business's revenue was up 18.3% compared to the same quarter last year. During the same period last year, the firm posted ($0.25) earnings per share. MaxLinear has set its Q3 2025 guidance at EPS. On average, equities analysts predict that MaxLinear, Inc will post -0.37 earnings per share for the current fiscal year.

MaxLinear Company Profile

MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.